<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> is a distinct type of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) characterised by refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo>, morphological abnormalities of megakaryocytes, and del(5q) as the sole cytogenetic abnormality </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast to patients with <z:e sem="disease" ids="C1292780" disease_type="Neoplastic Process" abbrv="">therapy-related MDS</z:e> with 5q deletions, <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> patients have a favourable prognosis and a low rate of transformation to <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously delineated a common deleted region of 5.6 Mb between the gene for fibroblast growth factor acidic (FGF1) and the subunit of interleukin 12 (IL12B) in two patients with <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> and small deletions, del(5)(q31q33) </plain></SENT>
<SENT sid="3" pm="."><plain>The present study used fluorescence in situ hybridisation (FISH) analysis of these and a third <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> patient with a small deletion, del(5)(q33q34), to refine further the critical deleted region </plain></SENT>
<SENT sid="4" pm="."><plain>This resulted in the narrowing of the common deleted region within 5q31.3-5q33 to approximately 3 Mb, flanked by the adrenergic receptor beta 2 (ADRB2) and IL/2B genes </plain></SENT>
<SENT sid="5" pm="."><plain>The common region of loss in these three <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> patients includes the macrophage colony-stimulating factor-1 receptor (CSF1R), secreted protein, acidic, cysteine-rich (SPARC), and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptor (GR1A1) genes </plain></SENT>
<SENT sid="6" pm="."><plain>This <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> critical region is telomeric to and distinct from the other critical regions on 5q associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
</text></document>